Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13D/A for Repare Therapeutics Inc. Common Shares, no par value (RPTX).
- Disclosed ownership: 24%.
- Date of event: 20 Nov 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 24% ownership in Repare Therapeutics Inc. Common Shares, no par value (RPTX) on 20 Nov 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 12% | 5,309,432 | 0 | 5,309,432 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0000918923 |
| BVF I GP LLC | 12% | 5,309,432 | 0 | 5,309,432 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001803805 |
| BIOTECHNOLOGY VALUE FUND II LP | 10% | 4,308,573 | 0 | 4,308,573 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001102444 |
| BVF II GP LLC | 10% | 4,308,573 | 0 | 4,308,573 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001803806 |
| Biotechnology Value Trading Fund OS LP | 1.3% | 548,938 | 0 | 548,938 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001660683 |
| BVF Partners OS Ltd. | 1.3% | 548,938 | 0 | 548,938 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001660684 |
| BVF GP HOLDINGS LLC | 22% | 9,618,005 | 0 | 9,618,005 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001803809 |
| BVF PARTNERS L P/IL | 24% | 10,333,600 | 0 | 10,333,600 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001055947 |
| BVF INC/IL | 24% | 10,333,600 | 0 | 10,333,600 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | 0001056807 |
| LAMPERT MARK N | 24% | 10,333,600 | 0 | 10,333,600 | /s/ Mark N. Lampert | Mark N. Lampert | 0001233840 |